Ovarian Cancer Response Scoring (OCRS): Validation of a system to quantify histopathological response to neoadjuvant chemotherapy in high-grade serous ovarian cancer

被引：0
|
作者：
Singh, N. [1 ]
Said, I. [1 ]
Faruqi, A. [1 ]
Gilks, B. [1 ]
Le, N. [1 ]
Boehm, S. [1 ]
机构：
[1] Barts Hlth NHS Trust, Dept Cellular Pathol, London, England
来源：
VIRCHOWS ARCHIV | 2014年 / 465卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-14-004
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [41] Histopathology and proteomics are synergistic for high-grade serous ovarian cancer platinum response prediction
    Kilim, Oz
    Olar, Alex
    Biricz, Andras
    Madaras, Lilla
    Pollner, Peter
    Szallasi, Zoltan
    Sztupinszki, Zsofia
    Csabai, Istvan
    NPJ PRECISION ONCOLOGY, 2025, 9 (01)
  • [42] Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer
    Morgan, Robert D.
    Wang, Xin
    Barnes, Bethany M.
    Spurgeon, Laura
    Carrot, Aurore
    Netto, Daniel
    Hasan, Jurjees
    Mitchell, Claire
    Salih, Zena
    Desai, Sudha
    Shaw, Joseph
    Winter-Roach, Brett
    Schlecht, Helene
    Burghel, George J.
    Clamp, Andrew R.
    Edmondson, Richard J.
    You, Benoit
    Evans, D. Gareth R.
    Jayson, Gordon C.
    Taylor, Stephen S.
    BRITISH JOURNAL OF CANCER, 2024, 131 (12) : 1919 - 1927
  • [43] PLOIDY LEVEL, HISTOPATHOLOGICAL DIFFERENTIATION AND RESPONSE TO CHEMOTHERAPY IN SEROUS OVARIAN-CANCER
    JAKOBSEN, A
    BICHEL, P
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (11): : 1589 - 1593
  • [44] The Prognostic Role of Histopathological Tumour Response Following Neoadjuvant Chemotherapy in High Grade Serous Tubo-Ovarian Carcinoma
    Coghlan, E.
    Munro, A.
    Bulsara, M.
    Magee, D.
    Stewart, C.
    Tang, A.
    Koay, E.
    Cohen, P.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2016, 56 : 22 - 22
  • [45] HISTOPATHOLOGICAL RESPONSE ON CLINICORADIOLOGICAL PRESENTATION AND PROGNOSIS OF PATIENTS WITH ADVANCED HIGH GRADE SEROUS OVARIAN CARCINOMA TREATED WITH NEOADJUVANT CHEMOTHERAPY
    Lopes, A.
    Genta, M. L. Nogueira D.
    da Costa Miranda, V.
    Mendonza Lopez, R. V.
    Marino Carvalho, F.
    Paula Carvalho, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A48 - A49
  • [46] Acquired chemotherapy resistance in high-grade serous ovarian cancer patients.
    Christie, Elizabeth L.
    Beach, Jessica
    Etemadmoghadam, Dariush
    Garsed, Dale
    Patch, Ann-Marie
    Fereday, Sian
    Pattnaik, Swetansu
    Brady, Samuel
    Bild, Andrea
    Bowtell, David D. L.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 20 - 20
  • [47] Understanding the impact of chemotherapy on the immune landscape of high-grade serous ovarian cancer
    Vanguri, Rami
    Benhamida, Jamal
    Young, Jonathan H.
    Li, Yanyun
    Zivanovic, Oliver
    Chi, Dennis
    Snyder, Alexandra
    Hollmann, Travis J.
    Mager, Katherine L.
    GYNECOLOGIC ONCOLOGY REPORTS, 2022, 39
  • [48] The Changing View of High-Grade Serous Ovarian Cancer
    Berns, Els M. J. J.
    Bowtell, David D.
    CANCER RESEARCH, 2012, 72 (11) : 2701 - 2704
  • [49] The genesis and evolution of high-grade serous ovarian cancer
    Bowtell, David D. L.
    NATURE REVIEWS CANCER, 2010, 10 (11) : 803 - 808
  • [50] The genesis and evolution of high-grade serous ovarian cancer
    David D. L. Bowtell
    Nature Reviews Cancer, 2010, 10 : 803 - 808
12345